Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
6.99M
-
Shares change
-
+2.49M
-
Total reported value, excl. options
-
$4.4M
-
Value change
-
+$1.25M
-
Number of buys
-
9
-
Number of sells
-
-27
-
Price
-
$0.63
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2019
47 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q3 2019.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.99M shares
of 77M outstanding shares and own 9.08% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.75M shares), VANGUARD GROUP INC (1.03M shares), BlackRock Inc. (571K shares), MILLENNIUM MANAGEMENT LLC (281K shares), GEODE CAPITAL MANAGEMENT, LLC (245K shares), SIGNATUREFD, LLC (184K shares), FIRST MANHATTAN CO (175K shares), Tekla Capital Management LLC (165K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (90K shares), and WELLINGTON MANAGEMENT GROUP LLP (63.9K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.